Back to search
Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals.
Data up to Jan 2025
Published1988
Citations60
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
No citing papers found in database